
According to Silvia Giovannini and colleagues from the Università Cattolica del Sacro Cuore in Rome, Italy, recent research has correlated sortilin and omentin-1 in the blood with the severity of peripheral artery disease (PAD). The investigators conducted a study to evaluate the feasibility of the sortilitn:omentin-1 ratio as an “easy-to-measure marker in peripheral artery disease (PAD) in type-2 diabetic patients.” According to the authors’ report, published in Mechanisms of Ageing and Development, “the sortilin to omentin-1 ratio appears to be a predictive factor for PAD in patients with type-2 diabetes and it may be a promising marker for clinically significant atherosclerosis of the lower limbs.”
Sortilin to Omentin-1 Ratio Study Objective
Authors felt that deeper understanding of the potential role of the sortilin to omentin-1 ratio could improve the management of elderly patients with type-2 diabetes. Their study included a total of 295 patients with diabetes, including 179 with clinically significant lower limb PAD. Patients’ serum levels were measured and examined for associations with clinical characteristics and outcomes.